Related references
Note: Only part of the references are listed.Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Statin use and risk of pancreatic cancer: a meta-analysis
Xiaobing Cui et al.
CANCER CAUSES & CONTROL (2012)
Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity
Jie Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways
Jun-ichi Hanai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production
Jie Chen et al.
MOLECULAR ONCOLOGY (2012)
Stain use and the risk of female lung cancer: A population-based case-control study
Meng-Hsuan Cheng et al.
LUNG CANCER (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Exposure to statins and risk of common cancers: a series of nested case-control studies
Yana Vinogradova et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort
Eric J. Jacobs et al.
CANCER RESEARCH (2011)
Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity
In Hae Park et al.
INVESTIGATIONAL NEW DRUGS (2011)
Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin
Ki-Eun Hwang et al.
INVESTIGATIONAL NEW DRUGS (2011)
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation Modulation of Molecular Pathways of Radioresistance and Tumor Suppression
Toran Sanli et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Statin-triggered cell death in primary human lung mesenchyrnal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c
Saeid Ghavami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Incidence of cancer and statin usage-record linkage study
Jari Haukka et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
In Hae Park et al.
INVESTIGATIONAL NEW DRUGS (2010)
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway
Yasuhiro Kidera et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation
Patrick C. Raemer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The double-edged sword of statin immunomodulation
Mark R. Goldstein et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4(+)CD25(+) T cells
Karin Mausner-Fainberg et al.
ATHEROSCLEROSIS (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The association between statins and cancer incidence in a veterans population
Wildon R. Farwell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent
Elena Maksimova et al.
LUNG (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Statins reduce the risk of lung cancer in humans* - A large case-control study of US veterans
Vikas Khurana et al.
CHEST (2007)
Statin use and the risk of 10 cancers
Patricia F. Coogan et al.
EPIDEMIOLOGY (2007)
Statins and the risk of lung, breast, and colorectal cancer in the elderly
Soko Setoguchi et al.
CIRCULATION (2007)
Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study
Shinichi Sato et al.
JOURNAL OF EPIDEMIOLOGY (2006)
Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling
UK Khanzada et al.
ONCOGENE (2006)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
TE Strandberg et al.
LANCET (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
CD Furberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA
HJ Park et al.
CIRCULATION RESEARCH (2002)
Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas
J Dimitroulakos et al.
NEOPLASIA (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis
T Kusama et al.
GASTROENTEROLOGY (2002)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer -: A nested case-control study
L Blais et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
